Literature DB >> 18353754

The timing of development and subsequent clinical course of heart failure after a myocardial infarction.

Azam Torabi1, John G F Cleland, Nasrin K Khan, Puan H Loh, Andrew L Clark, Farqad Alamgir, John L Caplin, Alan S Rigby, Kevin Goode.   

Abstract

AIMS: Myocardial infarction (MI) is a common cause of heart failure (HF), which may develop early and persist or resolve, or develop late. The cumulative incidence, persistence, and resolution of HF after MI are poorly described. The aim of this study is to describe the natural history and prognosis of HF after an MI. METHODS AND
RESULTS: Patients with a death or discharge diagnosis of MI in 1998 were identified from records of hospitals providing services to a local community of 600 000 people. Records were scrutinized to identify the development of HF, defined as signs and symptoms consistent with that diagnosis and treated with loop diuretics. HF was considered to have resolved if diuretics could be stopped without recurrent symptoms. Totally, 896 patients were identified of whom 54% had died by December 2005. During the index admission, 199 (22.2%) patients died, many with HF, and a further 182 (20.3%) patients developed HF that persisted until discharge, of whom 121 died subsequent to discharge. Of 74 patients with transient HF that resolved before discharge, 41 had recurrent HF and 38 died during follow-up. After discharge, 145 (33%) patients developed HF for the first time, of whom 76 died during follow-up. Overall, of 281 deaths occurring after discharge, 235 (83.6%) were amongst inpatients who first developed HF.
CONCLUSION: The development of HF precedes death in most patients who die in the short- or long-term following an MI. Prevention of HF, predominantly by reducing the extent of myocardial damage and recurrent MI, and subsequent management could have a substantial impact on prognosis.

Entities:  

Mesh:

Year:  2008        PMID: 18353754     DOI: 10.1093/eurheartj/ehn096

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  41 in total

Review 1.  Explicit risk in acute coronary syndrome management.

Authors:  Merril L Knudtson; Colleen M Norris; P Diane Galbraith; Jaro Hubacek; William A Ghali
Journal:  Can J Cardiol       Date:  2009-06       Impact factor: 5.223

2.  Fragmented QRS in prediction of cardiac deaths and heart failure hospitalizations after myocardial infarction.

Authors:  Petri Korhonen; Terhi Husa; Teijo Konttila; Ilkka Tierala; Markku Mäkijärvi; Heikki Väänänen; Janne Ojanen; Aki Vehtari; Lauri Toivonen
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-04       Impact factor: 1.468

3.  Heart failure in post-MI patients with persistent IRA occlusion: prevalence, risk factors, and the long-term effect of PCI in the Occluded Artery Trial (OAT).

Authors:  Rahul R Jhaveri; Harmony R Reynolds; Stuart D Katz; Raban Jeger; Elzbieta Zinka; Sandra A Forman; Gervasio A Lamas; Judith S Hochman
Journal:  J Card Fail       Date:  2012-11       Impact factor: 5.712

Review 4.  Acute heart failure and cardiogenic shock: a multidisciplinary practical guidance.

Authors:  A Mebazaa; H Tolppanen; C Mueller; J Lassus; S DiSomma; G Baksyte; M Cecconi; D J Choi; A Cohen Solal; M Christ; J Masip; M Arrigo; S Nouira; D Ojji; F Peacock; M Richards; N Sato; K Sliwa; J Spinar; H Thiele; M B Yilmaz; J Januzzi
Journal:  Intensive Care Med       Date:  2015-09-14       Impact factor: 17.440

5.  30-year trends in heart failure in patients hospitalized with acute myocardial infarction.

Authors:  David D McManus; Marcello Chinali; Jane S Saczynski; Joel M Gore; Jorge Yarzebski; Frederick A Spencer; Darleen Lessard; Robert J Goldberg
Journal:  Am J Cardiol       Date:  2011-02-01       Impact factor: 2.778

6.  Integrated protein network and microarray analysis to identify potential biomarkers after myocardial infarction.

Authors:  Yvan Devaux; Francisco Azuaje; Mélanie Vausort; Céline Yvorra; Daniel R Wagner
Journal:  Funct Integr Genomics       Date:  2010-04-23       Impact factor: 3.410

7.  Integrative pathway-centric modeling of ventricular dysfunction after myocardial infarction.

Authors:  Francisco Azuaje; Yvan Devaux; Daniel R Wagner
Journal:  PLoS One       Date:  2010-03-11       Impact factor: 3.240

8.  Prevalence and 1-year prognosis of transient heart failure following coronary revascularization.

Authors:  Marco Ambrosetti; Raffaele Griffo; Roberto Tramarin; Francesco Fattirolli; Pier Luigi Temporelli; Pompilio Faggiano; Stefania De Feo; Anna Rita Vestri; Francesco Giallauria; Cesare Greco
Journal:  Intern Emerg Med       Date:  2013-10-22       Impact factor: 3.397

Review 9.  Nanoscale Technologies for Prevention and Treatment of Heart Failure: Challenges and Opportunities.

Authors:  Mohammad Javad Hajipour; Mehdi Mehrani; Seyed Hesameddin Abbasi; Ahmad Amin; Seyed Ebrahim Kassaian; Jessica C Garbern; Giulio Caracciolo; Steven Zanganeh; Mitra Chitsazan; Haniyeh Aghaverdi; Seyed Mehdi Kamali Shahri; Aliakbar Ashkarran; Mohammad Raoufi; Holly Bauser-Heaton; Jianyi Zhang; Jochen D Muehlschlegel; Anna Moore; Richard T Lee; Joseph C Wu; Vahid Serpooshan; Morteza Mahmoudi
Journal:  Chem Rev       Date:  2019-09-06       Impact factor: 60.622

10.  The Difference on Features of Fragmented QRS Complex and Influences on Mortality in Patients with Acute Coronary Syndrome.

Authors:  Di Liang; Jingyi Zhang; Li Lin; Wenxia Zong
Journal:  Acta Cardiol Sin       Date:  2017-11       Impact factor: 2.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.